Nektar completes enrollment for alopecia study of rezpegaldesleukin February 26, 2025 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:FDA Grants Priority Review to Merck's Application for KEYTRUDA ® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinom Back: All Posts Next:Kairos Pharma reports promising preclinical cancer data